Genes, Pain and Medication: Q&A with Dr. Catrina Loucks

For some children with cancer the most painful part of their journey is when they start receiving life-saving treatment. To improve care for these and other sick children, it’s essential to understand why pain can be more intense in some kids than others, and how pain medications can potentially cause harmful reactions. To answer these questions, Dr. Catrina Loucks is studying genes…
Read More
Determining whether a patient has a predisposition to cancers or other harmful conditions can be a game changer for clinicians considering the benefits and risks of invasive procedures. About a decade ago, clinical medical geneticist Dr. Cornelius Boerkoel met a patient with characteristics of a disorder that could predispose him to certain types of cancer. The patient’s features suggested, but did not…
Read More
Xenon Pharmaceuticals, a neurology-focused biopharmaceutical company, today announced that its collaboration to develop treatments for epilepsy with Neurocrine Biosciences, Inc. achieved a regulatory milestone with the approval of a clinical trial application (CTA) in Europe, triggering an aggregate payment of $10.0 million to Xenon. Mr. Ian Mortimer, Xenon’s President and Chief Executive Officer stated, “This $10 million regulatory milestone from…
Read More
Dr. Zoubeidi led an international team that has published their discovery providing mechanistic insights into prostate cancer resistant to powerful hormone therapy, and proposes a potential treatment regime for reversing currently treatment-resistant phenotypes. This work was published online on September 6, 2021 in the high-impact journal Nature Cell Biology , along with a News and Views article focusing on this publication. The team investigated a…
Read More
Eyam Vaccine and Immunotherapeutics (EYAM), a next-generation vaccine biotechnology company, announced today an agreement with Veristat, a scientific-minded, global clinical research organization (CRO), to plan and coordinate clinical trials of their vaccine program against SARS-CoV-2. “This agreement builds a partnership with a global clinical research organization that has conducted COVID-19 trials around the world. Working with Veristat to plan and implement our clinical…
Read More

A Canadian First in CAR-T Cell Treatment for Adult Leukemia and Lymphoma

A study co-led by Dr. Kevin Hay from Vancouver Coastal Health Research Institute (VCHRI) and Dr. Natasha Kekre at The Ottawa Hospital is investigating the use of specialized chimeric antigen receptor T (CAR-T) cells to treat CD19 positive (CD19+) acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL). This first-of-its-kind clinical trial in Canada involves manufacturing and administering a CLIC-1901 cell therapy, which…
Read More
STEMCELL Technologies announces the launch of human pluripotent stem cell (hPSC) characterization and banking services in partnership with WiCell®. These services, offered through STEMCELL’s Contract Assay Services division, will provide researchers with comprehensive cell quality assessments and enable them to generate cell banks using standardized practices. Ultimately, this will reduce variability and improve reproducibility for various downstream applications, including disease modeling, drug discovery, toxicology…
Read More
Ever wondered how you can make artwork with biological reagents found in the lab? How about exploring the latest bleeding-edge research in science and medicine? If these topics interest you, then you won’t want to miss out on this event recap of CBR-SBME Research Day 2021! The Centre for Blood Research (CBR) and School of Biomedical Engineering (SBME) communities gathered online for CBR-SBME Research Day on…
Read More

TFRI launches 2021 Terry Fox Run Challenge

he Terry Fox Research Institute (TFRI) is happy to launch its 2021 Terry Fox Run Challenge, an annual event in which our research teams look to claim top honours by raising the most funds for cancer research. Last year, 28 teams participated in the challenge, raising over $98,000 for cancer research. For the third year in a row, the Vancouver Prostate…
Read More